Wai Yuen Tong Medicine Holdings Limited

SEHK:897 Stock Report

Market Cap: HK$229.5m

Wai Yuen Tong Medicine Holdings Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Ching Ho Tang

Chief executive officer

HK$23.6m

Total compensation

CEO salary percentage44.6%
CEO tenure6.5yrs
CEO ownershipn/a
Management average tenure3.4yrs
Board average tenure6.5yrs

Recent management updates

Recent updates

Wai Yuen Tong Medicine Holdings Limited's (HKG:897) Share Price Boosted 51% But Its Business Prospects Need A Lift Too

Jul 26
Wai Yuen Tong Medicine Holdings Limited's (HKG:897) Share Price Boosted 51% But Its Business Prospects Need A Lift Too

Investors Give Wai Yuen Tong Medicine Holdings Limited (HKG:897) Shares A 46% Hiding

Mar 11
Investors Give Wai Yuen Tong Medicine Holdings Limited (HKG:897) Shares A 46% Hiding

The Strong Earnings Posted By Wai Yuen Tong Medicine Holdings (HKG:897) Are A Good Indication Of The Strength Of The Business

Dec 28
The Strong Earnings Posted By Wai Yuen Tong Medicine Holdings (HKG:897) Are A Good Indication Of The Strength Of The Business

Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?

Jul 11
Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?

Wai Yuen Tong Medicine Holdings (HKG:897) Takes On Some Risk With Its Use Of Debt

Jul 05
Wai Yuen Tong Medicine Holdings (HKG:897) Takes On Some Risk With Its Use Of Debt

Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?

Mar 08
Is Wai Yuen Tong Medicine Holdings (HKG:897) A Risky Investment?

Increases to Wai Yuen Tong Medicine Holdings Limited's (HKG:897) CEO Compensation Might Cool off for now

Aug 18
Increases to Wai Yuen Tong Medicine Holdings Limited's (HKG:897) CEO Compensation Might Cool off for now

Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?

Mar 17
Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?

Wai Yuen Tong Medicine Holdings' (HKG:897) Shareholders Are Down 75% On Their Shares

Jan 22
Wai Yuen Tong Medicine Holdings' (HKG:897) Shareholders Are Down 75% On Their Shares

Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?

Dec 16
Health Check: How Prudently Does Wai Yuen Tong Medicine Holdings (HKG:897) Use Debt?

CEO Compensation Analysis

How has Ching Ho Tang's remuneration changed compared to Wai Yuen Tong Medicine Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024HK$24mHK$11m

-HK$27m

Sep 30 2023n/an/a

HK$36m

Jun 30 2023n/an/a

HK$8m

Mar 31 2023HK$16mHK$15m

-HK$16m

Dec 31 2022n/an/a

-HK$98m

Sep 30 2022n/an/a

-HK$176m

Jun 30 2022n/an/a

-HK$143m

Mar 31 2022HK$9mHK$8m

-HK$109m

Dec 31 2021n/an/a

-HK$122m

Sep 30 2021n/an/a

-HK$135m

Jun 30 2021n/an/a

-HK$255m

Mar 31 2021HK$8mHK$8m

-HK$376m

Dec 31 2020n/an/a

-HK$98m

Sep 30 2020n/an/a

HK$179m

Jun 30 2020n/an/a

HK$309m

Mar 31 2020HK$15mHK$12m

HK$439m

Dec 31 2019n/an/a

HK$253m

Sep 30 2019n/an/a

HK$66m

Jun 30 2019n/an/a

HK$71m

Mar 31 2019HK$14mHK$12m

HK$75m

Dec 31 2018n/an/a

HK$20m

Sep 30 2018n/an/a

-HK$35m

Jun 30 2018n/an/a

-HK$75m

Mar 31 2018HK$13mHK$12m

-HK$116m

Compensation vs Market: Ching Ho's total compensation ($USD3.03M) is above average for companies of similar size in the Hong Kong market ($USD233.31K).

Compensation vs Earnings: Ching Ho's compensation has increased whilst the company is unprofitable.


CEO

Ching Ho Tang (62 yo)

6.5yrs

Tenure

HK$23,551,000

Compensation

Mr. Ching Ho Tang, GBS, SBS, JP is Chairman of China Agri-Products Exchange Limited since February 8, 2021 and re-designated as its Executive Director since October 01, 2022. Mr. Tang Co-founded Wang On Gr...


Leadership Team

NamePositionTenureCompensationOwnership
Ching Ho Tang
Executive Chairman & MD6.5yrsHK$23.55mno data
Wai Man Tang
Executive Director6.5yrsHK$2.20mno data
Man Yee Law
Assistant GM of Purchasing Processing & Executive Director3.7yrsHK$909.00kno data
Seung Ming Wong
Financial Controller2.7yrsno datano data
Siu Fai Chan
Head of Factory Operations3.1yrsno datano data
Yee Man Ng
Company Secretaryless than a yearno datano data

3.4yrs

Average Tenure

55yo

Average Age

Experienced Management: 897's management team is considered experienced (3.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ching Ho Tang
Executive Chairman & MD23.2yrsHK$23.55mno data
Wai Man Tang
Executive Director6.5yrsHK$2.20mno data
Man Yee Law
Assistant GM of Purchasing Processing & Executive Director3.7yrsHK$909.00kno data
Ka Fai Li
Independent Non-Executive Director9.6yrsHK$204.00kno data
Man Ho Siu
Independent Non-Executive Director23.2yrsHK$184.00kno data
Wing Hang Sit
Independent Non-Executive Directorless than a yearHK$45.00kno data
Wing Kwong Chan
Independent Non-Executive Directorless than a yearHK$45.00kno data

6.5yrs

Average Tenure

61yo

Average Age

Experienced Board: 897's board of directors are considered experienced (6.5 years average tenure).